How does cytomegalovirus infection present in immunocompromised patients?

Clinical Presentation of Cytomegalovirus in Immunocompromised Patients

CMV infection in immunocompromised patients most commonly presents as retinitis (the leading manifestation), followed by gastrointestinal disease (colitis and esophagitis), and less frequently as pneumonitis or neurologic disease, with clinical manifestations occurring almost exclusively when CD4+ counts fall below 50 cells/µL. 1, 2

Risk Stratification

CMV end-organ disease develops in patients with:

• CD4+ T lymphocyte counts <50 cells/µL (primary threshold)
• Previous opportunistic infections, particularly MAC disease
• High plasma HIV-1 RNA levels (>100,000 copies/mL)
• Patients not receiving or failing antiretroviral therapy 1

The majority of infections derive from reactivation of latent infection rather than primary infection 1.

Organ-Specific Clinical Manifestations

Retinitis (Most Common - 30% of AIDS patients with CMV)

Peripheral retinitis:

• May be completely asymptomatic
• Floaters, scotomata, or peripheral visual field defects

Central retinal lesions:

• Decreased visual acuity
• Central field defects

Ophthalmologic findings:

• Fluffy yellow-white perivascular retinal infiltrates (focal necrotizing retinitis)
• With or without intraretinal hemorrhage
• Minimal vitreous inflammation (unless immune recovery occurs with ART)
• Sheathed blood vessels near lesions
• Occasionally granular appearance 1, 2

Natural history:

• Initially unilateral in two-thirds of patients
• Without treatment, progresses to bilateral disease in majority
• Invariable progression within 10-21 days without therapy
• Characteristic "brushfire pattern" with granular white leading edge advancing before atrophic gliotic scar 2

Gastrointestinal Disease

Colitis (5-10% of CMV end-organ disease):

• Fever, weight loss, anorexia
• Abdominal pain
• Debilitating diarrhea
• Malaise
• Life-threatening complications: extensive mucosal hemorrhage and perforation 1, 2

Esophagitis (<5-10% of CMV end-organ disease):

• Fever
• Odynophagia (painful swallowing)
• Nausea
• Mid-epigastric or retrosternal discomfort 1, 2, 3

Neurologic Disease

CMV dementia:

• Lethargy, confusion, fever
• Mimics HIV-1 dementia clinically
• CSF: lymphocytic pleocytosis (or mixed neutrophils/lymphocytes), low-to-normal glucose, normal-to-elevated protein 1

Ventriculoencephalitis:

• More acute course than dementia
• Focal neurologic signs
• Cranial nerve palsies or nystagmus
• Rapid progression to death
• Imaging: periventricular enhancement on CT/MRI (distinguishes from HIV-related disease) 1, 2

Polyradiculomyelopathy (Guillain-Barré-like syndrome):

• Urinary retention
• Progressive bilateral leg weakness
• Progression over several weeks to loss of bowel/bladder control
• Flaccid paraplegia
• Sacral paresthesia may occur
• CSF: neutrophilic pleocytosis (100-200 neutrophils/µL with some erythrocytes), hypoglycorrhachia, elevated protein 1, 2

Pneumonitis (Uncommon)

When present:

• Shortness of breath
• Dyspnea on exertion
• Nonproductive cough
• Hypoxemia
• Interstitial infiltrates on chest radiograph 1

Critical Diagnostic Considerations

CMV viremia detection:

• PCR or antigen assays detect viremia
• Viremia present in end-organ disease BUT also may occur without end-organ disease
• Viremia alone does NOT equal end-organ disease 1, 2

Serology limitations:

• Negative IgG suggests CMV unlikely as causative agent
• However, severely immunosuppressed patients may serorevert from positive to negative
• Negative CMV IgG does not definitively eliminate CMV disease 1

Definitive diagnosis requires:

• Retinitis: Characteristic funduscopic findings by experienced ophthalmologist (95% positive predictive value) 2
• GI disease: Endoscopic visualization of mucosal ulcerations PLUS biopsy showing characteristic intranuclear and intracytoplasmic inclusions 1, 2
• Neurologic disease: Clinical presentation plus CSF findings and imaging characteristics 1

Common Pitfalls

1. Assuming CMV viremia equals CMV disease - requires histopathologic confirmation or characteristic clinical findings 4
2. Missing bilateral progression - unilateral retinitis progresses to bilateral without treatment 2
3. Overlooking GI perforation risk - CMV colitis can cause life-threatening hemorrhage and perforation 1, 2
4. Confusing CMV dementia with HIV dementia - periventricular enhancement on imaging distinguishes CMV ventriculoencephalitis 1
5. Relying on serology in severely immunosuppressed patients - may be unreliable 1, 3